BBI-5000

Fresh Tracks Therapeutics, Inc. · Phase 1 active Small molecule

At a glance

Generic name	BBI-5000
Sponsor	Fresh Tracks Therapeutics, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BBI-5000 CI brief — competitive landscape report
BBI-5000 updates RSS · CI watch RSS
Fresh Tracks Therapeutics, Inc. portfolio CI